PH23125A - Diagnostic system for the detection of cytomega-lovirus - Google Patents

Diagnostic system for the detection of cytomega-lovirus

Info

Publication number
PH23125A
PH23125A PH32234A PH32234A PH23125A PH 23125 A PH23125 A PH 23125A PH 32234 A PH32234 A PH 32234A PH 32234 A PH32234 A PH 32234A PH 23125 A PH23125 A PH 23125A
Authority
PH
Philippines
Prior art keywords
diagnostic system
cytomega
lovirus
detection
cytomegalovirus
Prior art date
Application number
PH32234A
Other languages
English (en)
Inventor
Michael B A Oldstone
George Rice
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/607,387 external-priority patent/US4818678A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of PH23125A publication Critical patent/PH23125A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Emergency Alarm Devices (AREA)
  • Control Of Combustion (AREA)
  • Examining Or Testing Airtightness (AREA)
  • Apparatus For Making Beverages (AREA)
PH32234A 1984-05-04 1985-05-07 Diagnostic system for the detection of cytomega-lovirus PH23125A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/607,387 US4818678A (en) 1984-05-04 1984-05-04 Diagnostic system for the detection of cytomegalovirus
US06/726,454 US4783399A (en) 1984-05-04 1985-04-29 Diagnostic system for the detection of cytomegalovirus

Publications (1)

Publication Number Publication Date
PH23125A true PH23125A (en) 1989-05-05

Family

ID=27085503

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32234A PH23125A (en) 1984-05-04 1985-05-07 Diagnostic system for the detection of cytomega-lovirus

Country Status (13)

Country Link
US (1) US4783399A (fr)
EP (1) EP0179152B1 (fr)
JP (1) JPH0646196B2 (fr)
AT (1) ATE71141T1 (fr)
AU (1) AU596073B2 (fr)
CA (1) CA1339515C (fr)
DE (1) DE3585075D1 (fr)
DK (1) DK173584B1 (fr)
IE (1) IE58445B1 (fr)
IL (1) IL75094A (fr)
NZ (1) NZ211989A (fr)
PH (1) PH23125A (fr)
WO (1) WO1985005123A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194256A (en) * 1984-08-21 1993-03-16 The Board Of Trustees Of The Leland Sanford Junior University Purified human cytomegalovirus protein
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
US5248768A (en) * 1986-11-24 1993-09-28 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus
US4908305A (en) * 1987-06-14 1990-03-13 The University Of Maryland Competitive elisa for determination of neutralizing IBDV antibody
US5547834A (en) * 1988-01-29 1996-08-20 Chiron Corporation Recombinant CMV neutralizing proteins
DE68929478T2 (de) * 1988-01-29 2004-04-29 Aventis Pasteur Rekombinante CMV-Neutralisierungsproteine
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
WO1991005876A1 (fr) * 1989-10-20 1991-05-02 Children's Biomedical Research Institute Cocktail d'anticorps monoclonaux specifiques du cytomegalovirus humain
US5750106A (en) * 1993-01-28 1998-05-12 Novartis Ag Human monoclonal antibodies to cytomegalovirus
RU2123188C1 (ru) * 1997-07-08 1998-12-10 Московский областной научно-исследовательский клинический институт Способ прогнозирования развития цитомегаловирусной инфекции у реципиентов почечных аллотрансплантатов
PT1737891E (pt) 2004-04-13 2013-04-16 Hoffmann La Roche Anticorpos anti p-selectina
HUE041957T2 (hu) 2006-12-01 2019-06-28 Novartis Ag Anti-P-szelektin antitestek és eljárások azok alkalmazására gyulladásos betegségek kezelésére
US8945565B2 (en) 2006-12-01 2015-02-03 Selexys Pharmaceuticals Corporation Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
US20110212096A1 (en) * 2006-12-01 2011-09-01 Scott Rollins Anti-p-selectin antibodies and methods of their use and identification
US7947274B2 (en) * 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
DK2352759T3 (en) 2008-07-16 2017-12-18 Inst Res Biomedicine ANTIBODIES THAT NEUTRALIZE HUMAN CYTOMEGALOVIRUS AND USE THEREOF
ES2531385T3 (es) * 2008-09-19 2015-03-13 Hoffmann La Roche Formulación que comprende un anticuerpo contra la selectina P
US20200087403A1 (en) 2017-03-15 2020-03-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions for the treatment of thrombosis in patients suffering from a myeloproliferative neoplasm
JP2020524283A (ja) 2017-06-20 2020-08-13 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 急性非代償性心不全（ａｄｈｆ）患者が凝固亢進状態を示すかどうかを同定するための方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4334016A (en) * 1980-06-19 1982-06-08 The Wistar Institute Of Anatomy And Biology Human osteogenic sarcoma cell line and use thereof for immunofluorescent antibody test
US4444878A (en) * 1981-12-21 1984-04-24 Boston Biomedical Research Institute, Inc. Bispecific antibody determinants
FR2543570B1 (fr) * 1983-03-31 1985-08-09 Pasteur Institut Anticorps monoclonaux anticytomegalovirus humains, hybridomes secreteurs de ces anticorps et polypeptides porteurs d'un determinant antigenique sequentiel de cytomegalovirus humains
GB8404368D0 (en) * 1984-02-20 1984-03-28 Cogent Ltd Monoclonal antibodies to human cytomegalovirus

Also Published As

Publication number Publication date
JPS61502026A (ja) 1986-09-18
US4783399A (en) 1988-11-08
NZ211989A (en) 1989-04-26
DK2486A (da) 1986-01-03
DK173584B1 (da) 2001-04-02
IE851115L (en) 1985-11-04
JPH0646196B2 (ja) 1994-06-15
IE58445B1 (en) 1993-09-22
EP0179152A4 (fr) 1988-03-07
AU596073B2 (en) 1990-04-26
DK2486D0 (da) 1986-01-03
ATE71141T1 (de) 1992-01-15
EP0179152B1 (fr) 1992-01-02
WO1985005123A1 (fr) 1985-11-21
IL75094A (en) 1992-01-15
AU4351985A (en) 1985-11-28
EP0179152A1 (fr) 1986-04-30
DE3585075D1 (de) 1992-02-13
CA1339515C (fr) 1997-10-28

Similar Documents

Publication Publication Date Title
PH23125A (en) Diagnostic system for the detection of cytomega-lovirus
Brown et al. Indirect 125I-labeled protein A assay for monoclonal antibodies to cell surface antigens
IL73437A (en) Method and test kit for detecting immune(clq)complexes in human serum by means of a mouse monoclonal antibody
Douillard et al. Enzyme-linked immunosorbent assay for screening monoclonal antibody production: use of intact cells as antigen
IL86676A0 (en) Cell line and monoclonal antibodies
GB8504104D0 (en) Hcmv monoclonal antibodies
EP0404912A4 (en) Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
KR890701632A (ko) 사람 인터루킨-4에 대한 모노클로날 항체 및 이를 생성하는 하이브리도마
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
JPS6428560A (en) Immunometric measurement
EP0157197A3 (en) Method for carrying out immunofluorescent assays
IL81941A (en) Immunoassay for detection of haptens with monoclonal antibodies produced by immunizing b-cells with an unconjugated hapten and fusing with an immortal cell line
KR900006779A (ko) 항원에 대해 특이적인 종류의 항체 측정 방법 및 이 방법을 실행하기 위한 시약
EP0174874A3 (fr) Lignée de cellules hybrides produisant un anticorps monoclonal cytolytique pour trichomonas vaginalis
Imai et al. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera
IL97350A0 (en) Hybridomas producing monoclonal antibodies specific for metolachlor,such antibodies and their use in immunoassays for metolachlor
CA2281262A1 (fr) Anticorps monoclonal anti-medullasine humaine, processus de production et dosage immunologique utilisant cet anticorps moinoclonal
Murray et al. Measurement of association constants in ELISA reactions between solid-phase antibody and fluid-phase biotinylated antigen
ZA861550B (en) Process and reagent for the determination of the luteinising hormone and monoclonal antibodies suitable therefor
JPS6459068A (en) Method for measuring human thyroxin binding globulin
RU93053072A (ru) МОНОКЛОНАЛЬНЫЙ АНТИ-D РЕАГЕНТ НА ОСНОВЕ ЧЕЛОВЕЧЕСКИХ IgM АНТИТЕЛ, СЕКРЕТИРУЕМЫХ ГЕТЕРОГИБРИДОМОЙ ЧЕЛОВЕК-МЫШЬ
JPS6457169A (en) Immunohistochemical analysis
Bocchieri An ELISA for anti-thymocyte autoantibody in NZB mice Comparison with the cytotoxic assay
EP0335263A3 (fr) Anticorps monoclonal contre la lymphotoxine humaine, hybridome le produisant, anticorps contre le peptide c-terminal de la lymphotoxine humaine et méthode de détection de la lymphotoxine humaine par ce moyen
Steinitz et al. A sensitive method for detecting cells coated with antibodies with human monoclonal rheumatoid factor produced in vitro